Gründer G
Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; German Center for Mental Health (DZPG), partner site Mannheim - Heidelberg - Ulm, Mannheim, Germany; Center for Innovative Psychiatry and Psychotherapy Research (ZIPP), Central Institute of Mental Health, Mannheim, Germany; MIND Foundation, Berlin, Germany; OVID Clinic Berlin GmbH, Berlin, Germany.
ArticlePsychedelics
How high ventilation breathwork alters consciousness: Hypoperfusion, network dynamics, and subjective experience.
ArticlePsilocybin
Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.
ArticlePsilocybin
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.
ArticlePsychedelics
Psychedelics: The pathway to implementation in the European healthcare systems.
ArticlePsychedelics
Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe's general change mechanisms.
ArticlePsilocybin
Compassionate use of psilocybin for treatment-resistant depression in Germany.
ArticlePsychedelics
Key competencies for psychedelic treatment in real-world mental health care settings.
ArticlePsilocybin
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
ArticlePsilocybin
[Acceptance of psilocybin-assisted therapy in German-speaking countries].
ArticleKetamine
[Mechanisms of action of antidepressive pharmacotherapy: brain and mind-body and environment].
ArticlePsilocybin
Psilocybin as a Disease-Modifying Drug—A Salutogenic Approach in Psychiatry.
ArticlePsychedelics
Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ).
ArticlePsilocybin
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.
ArticlePsilocybin
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.
ArticlePsilocybin
The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.
ArticlePsilocybin